nodes	percent_of_prediction	percent_of_DWPC	metapath
Lacosamide—CA6—submandibular gland—head and neck cancer	0.155	0.241	CbGeAlD
Lacosamide—CA6—saliva—head and neck cancer	0.0558	0.0866	CbGeAlD
Lacosamide—CA6—ear—head and neck cancer	0.051	0.0792	CbGeAlD
Lacosamide—CA3—ear—head and neck cancer	0.0483	0.075	CbGeAlD
Lacosamide—Cerebellar syndrome—Fluorouracil—head and neck cancer	0.0304	0.0857	CcSEcCtD
Lacosamide—CA6—exocrine gland—head and neck cancer	0.0282	0.0438	CbGeAlD
Lacosamide—CA6—hair follicle—head and neck cancer	0.0269	0.0418	CbGeAlD
Lacosamide—CA6—mouth—head and neck cancer	0.0211	0.0328	CbGeAlD
Lacosamide—CA3—mouth—head and neck cancer	0.02	0.031	CbGeAlD
Lacosamide—CA6—parotid gland—head and neck cancer	0.0147	0.0228	CbGeAlD
Lacosamide—CA6—saliva-secreting gland—head and neck cancer	0.0141	0.0219	CbGeAlD
Lacosamide—CA3—parotid gland—head and neck cancer	0.0139	0.0216	CbGeAlD
Lacosamide—Nystagmus—Vinblastine—head and neck cancer	0.013	0.0367	CcSEcCtD
Lacosamide—CA3—connective tissue—head and neck cancer	0.0122	0.019	CbGeAlD
Lacosamide—Atrial flutter—Docetaxel—head and neck cancer	0.0116	0.0326	CcSEcCtD
Lacosamide—Balance disorder—Fluorouracil—head and neck cancer	0.0112	0.0315	CcSEcCtD
Lacosamide—CA2—exocrine gland—head and neck cancer	0.00971	0.0151	CbGeAlD
Lacosamide—CA2—hair follicle—head and neck cancer	0.00925	0.0144	CbGeAlD
Lacosamide—Nystagmus—Fluorouracil—head and neck cancer	0.00853	0.0241	CcSEcCtD
Lacosamide—CA3—thyroid gland—head and neck cancer	0.00813	0.0126	CbGeAlD
Lacosamide—CA6—head—head and neck cancer	0.00761	0.0118	CbGeAlD
Lacosamide—CA4—neck—head and neck cancer	0.00749	0.0116	CbGeAlD
Lacosamide—CA2—mouth—head and neck cancer	0.00726	0.0113	CbGeAlD
Lacosamide—CA3—head—head and neck cancer	0.00721	0.0112	CbGeAlD
Lacosamide—Dysarthria—Fluorouracil—head and neck cancer	0.00645	0.0182	CcSEcCtD
Lacosamide—CA2—neck—head and neck cancer	0.00621	0.00965	CbGeAlD
Lacosamide—CA4—parotid gland—head and neck cancer	0.0061	0.00947	CbGeAlD
Lacosamide—SCN10A—lymphoid tissue—head and neck cancer	0.00606	0.00942	CbGeAlD
Lacosamide—CA4—saliva-secreting gland—head and neck cancer	0.00584	0.00907	CbGeAlD
Lacosamide—Euphoric mood—Fluorouracil—head and neck cancer	0.00524	0.0148	CcSEcCtD
Lacosamide—Depression—Vinblastine—head and neck cancer	0.00518	0.0146	CcSEcCtD
Lacosamide—CA5B—thyroid gland—head and neck cancer	0.00516	0.00802	CbGeAlD
Lacosamide—CA2—parotid gland—head and neck cancer	0.00505	0.00786	CbGeAlD
Lacosamide—CA3—lymph node—head and neck cancer	0.00505	0.00784	CbGeAlD
Lacosamide—CA1—lymphoid tissue—head and neck cancer	0.00502	0.0078	CbGeAlD
Lacosamide—SCN3A—thyroid gland—head and neck cancer	0.00502	0.0078	CbGeAlD
Lacosamide—Neutropenia—Hydroxyurea—head and neck cancer	0.00497	0.014	CcSEcCtD
Lacosamide—SCN10A—head—head and neck cancer	0.00488	0.00759	CbGeAlD
Lacosamide—Agranulocytosis—Vinblastine—head and neck cancer	0.00485	0.0137	CcSEcCtD
Lacosamide—CA2—saliva-secreting gland—head and neck cancer	0.00484	0.00752	CbGeAlD
Lacosamide—Hypoaesthesia—Vinblastine—head and neck cancer	0.00464	0.0131	CcSEcCtD
Lacosamide—CA5B—head—head and neck cancer	0.00458	0.00712	CbGeAlD
Lacosamide—CA4—trachea—head and neck cancer	0.0045	0.007	CbGeAlD
Lacosamide—SCN9A—lymph node—head and neck cancer	0.00449	0.00698	CbGeAlD
Lacosamide—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.00448	0.0126	CcSEcCtD
Lacosamide—SCN3A—head—head and neck cancer	0.00445	0.00692	CbGeAlD
Lacosamide—CA2—connective tissue—head and neck cancer	0.00445	0.00691	CbGeAlD
Lacosamide—Osteoarthritis—Fluorouracil—head and neck cancer	0.00443	0.0125	CcSEcCtD
Lacosamide—Hallucination—Hydroxyurea—head and neck cancer	0.00423	0.0119	CcSEcCtD
Lacosamide—Irritability—Fluorouracil—head and neck cancer	0.00422	0.0119	CcSEcCtD
Lacosamide—CA2—epithelium—head and neck cancer	0.00422	0.00656	CbGeAlD
Lacosamide—Ataxia—Fluorouracil—head and neck cancer	0.00416	0.0117	CcSEcCtD
Lacosamide—CA1—head—head and neck cancer	0.00404	0.00628	CbGeAlD
Lacosamide—Eosinophilia—Fluorouracil—head and neck cancer	0.00379	0.0107	CcSEcCtD
Lacosamide—Anaemia—Vinblastine—head and neck cancer	0.00375	0.0106	CcSEcCtD
Lacosamide—CA2—trachea—head and neck cancer	0.00373	0.0058	CbGeAlD
Lacosamide—Erythema—Hydroxyurea—head and neck cancer	0.0037	0.0104	CcSEcCtD
Lacosamide—Vertigo—Vinblastine—head and neck cancer	0.00365	0.0103	CcSEcCtD
Lacosamide—CA4—thyroid gland—head and neck cancer	0.00356	0.00554	CbGeAlD
Lacosamide—Anaemia—Hydroxyurea—head and neck cancer	0.00342	0.00965	CcSEcCtD
Lacosamide—SCN10A—lymph node—head and neck cancer	0.00342	0.00531	CbGeAlD
Lacosamide—Discomfort—Vinblastine—head and neck cancer	0.00341	0.00963	CcSEcCtD
Lacosamide—Atrial fibrillation—Docetaxel—head and neck cancer	0.00337	0.00951	CcSEcCtD
Lacosamide—CA2—lymphoid tissue—head and neck cancer	0.00325	0.00506	CbGeAlD
Lacosamide—CA5B—lymph node—head and neck cancer	0.00321	0.00498	CbGeAlD
Lacosamide—Agranulocytosis—Fluorouracil—head and neck cancer	0.00318	0.00898	CcSEcCtD
Lacosamide—CA4—head—head and neck cancer	0.00316	0.00491	CbGeAlD
Lacosamide—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00313	0.00883	CcSEcCtD
Lacosamide—SCN3A—lymph node—head and neck cancer	0.00312	0.00484	CbGeAlD
Lacosamide—Discomfort—Hydroxyurea—head and neck cancer	0.00311	0.00878	CcSEcCtD
Lacosamide—Hypoaesthesia—Fluorouracil—head and neck cancer	0.00305	0.00859	CcSEcCtD
Lacosamide—Ataxia—Docetaxel—head and neck cancer	0.003	0.00847	CcSEcCtD
Lacosamide—Paraesthesia—Vinblastine—head and neck cancer	0.00298	0.00839	CcSEcCtD
Lacosamide—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00296	0.00836	CcSEcCtD
Lacosamide—CA2—thyroid gland—head and neck cancer	0.00295	0.00459	CbGeAlD
Lacosamide—Liver function test abnormal—Docetaxel—head and neck cancer	0.00295	0.00832	CcSEcCtD
Lacosamide—Skin disorder—Hydroxyurea—head and neck cancer	0.00294	0.00828	CcSEcCtD
Lacosamide—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.00288	0.00811	CcSEcCtD
Lacosamide—Constipation—Vinblastine—head and neck cancer	0.00283	0.00799	CcSEcCtD
Lacosamide—CA1—lymph node—head and neck cancer	0.00283	0.0044	CbGeAlD
Lacosamide—Feeling abnormal—Vinblastine—head and neck cancer	0.00273	0.0077	CcSEcCtD
Lacosamide—Somnolence—Hydroxyurea—head and neck cancer	0.00269	0.00758	CcSEcCtD
Lacosamide—Erythema—Fluorouracil—head and neck cancer	0.00266	0.00752	CcSEcCtD
Lacosamide—Dyspepsia—Hydroxyurea—head and neck cancer	0.00266	0.0075	CcSEcCtD
Lacosamide—CA2—head—head and neck cancer	0.00262	0.00407	CbGeAlD
Lacosamide—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00261	0.00736	CcSEcCtD
Lacosamide—Fatigue—Hydroxyurea—head and neck cancer	0.00261	0.00735	CcSEcCtD
Lacosamide—Constipation—Hydroxyurea—head and neck cancer	0.00258	0.00729	CcSEcCtD
Lacosamide—Neutropenia—Docetaxel—head and neck cancer	0.00258	0.00728	CcSEcCtD
Lacosamide—Vision blurred—Fluorouracil—head and neck cancer	0.00251	0.00708	CcSEcCtD
Lacosamide—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00249	0.00702	CcSEcCtD
Lacosamide—Anaemia—Fluorouracil—head and neck cancer	0.00246	0.00695	CcSEcCtD
Lacosamide—Hypersensitivity—Vinblastine—head and neck cancer	0.00244	0.00689	CcSEcCtD
Lacosamide—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.00244	0.00688	CcSEcCtD
Lacosamide—Body temperature increased—Hydroxyurea—head and neck cancer	0.00239	0.00674	CcSEcCtD
Lacosamide—Asthenia—Vinblastine—head and neck cancer	0.00238	0.00671	CcSEcCtD
Lacosamide—Hepatobiliary disease—Docetaxel—head and neck cancer	0.00233	0.00657	CcSEcCtD
Lacosamide—Agranulocytosis—Docetaxel—head and neck cancer	0.0023	0.00648	CcSEcCtD
Lacosamide—Chest pain—Fluorouracil—head and neck cancer	0.00227	0.0064	CcSEcCtD
Lacosamide—Diarrhoea—Vinblastine—head and neck cancer	0.00227	0.00639	CcSEcCtD
Lacosamide—Discomfort—Fluorouracil—head and neck cancer	0.00224	0.00632	CcSEcCtD
Lacosamide—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00223	0.00628	CcSEcCtD
Lacosamide—CA4—lymph node—head and neck cancer	0.00221	0.00344	CbGeAlD
Lacosamide—Hepatitis—Docetaxel—head and neck cancer	0.00221	0.00623	CcSEcCtD
Lacosamide—Hypoaesthesia—Docetaxel—head and neck cancer	0.0022	0.0062	CcSEcCtD
Lacosamide—Confusional state—Fluorouracil—head and neck cancer	0.00219	0.00619	CcSEcCtD
Lacosamide—Dizziness—Vinblastine—head and neck cancer	0.00219	0.00618	CcSEcCtD
Lacosamide—Connective tissue disorder—Docetaxel—head and neck cancer	0.00217	0.00612	CcSEcCtD
Lacosamide—Asthenia—Hydroxyurea—head and neck cancer	0.00217	0.00611	CcSEcCtD
Lacosamide—Nervous system disorder—Fluorouracil—head and neck cancer	0.00213	0.00602	CcSEcCtD
Lacosamide—Vomiting—Vinblastine—head and neck cancer	0.00211	0.00594	CcSEcCtD
Lacosamide—Erythema multiforme—Docetaxel—head and neck cancer	0.00209	0.00589	CcSEcCtD
Lacosamide—Headache—Vinblastine—head and neck cancer	0.00208	0.00585	CcSEcCtD
Lacosamide—Diarrhoea—Hydroxyurea—head and neck cancer	0.00207	0.00583	CcSEcCtD
Lacosamide—Eye disorder—Docetaxel—head and neck cancer	0.00206	0.00582	CcSEcCtD
Lacosamide—Cardiac disorder—Docetaxel—head and neck cancer	0.00205	0.00578	CcSEcCtD
Lacosamide—Bortezomib—CYP1A1—head and neck cancer	0.00202	1	CrCbGaD
Lacosamide—Dizziness—Hydroxyurea—head and neck cancer	0.002	0.00564	CcSEcCtD
Lacosamide—Immune system disorder—Docetaxel—head and neck cancer	0.002	0.00563	CcSEcCtD
Lacosamide—Nausea—Vinblastine—head and neck cancer	0.00197	0.00555	CcSEcCtD
Lacosamide—Insomnia—Fluorouracil—head and neck cancer	0.00197	0.00555	CcSEcCtD
Lacosamide—Paraesthesia—Fluorouracil—head and neck cancer	0.00195	0.00551	CcSEcCtD
Lacosamide—Mental disorder—Docetaxel—head and neck cancer	0.00194	0.00546	CcSEcCtD
Lacosamide—Somnolence—Fluorouracil—head and neck cancer	0.00193	0.00545	CcSEcCtD
Lacosamide—Erythema—Docetaxel—head and neck cancer	0.00192	0.00543	CcSEcCtD
Lacosamide—Vomiting—Hydroxyurea—head and neck cancer	0.00192	0.00542	CcSEcCtD
Lacosamide—Dyspepsia—Fluorouracil—head and neck cancer	0.00191	0.0054	CcSEcCtD
Lacosamide—Rash—Hydroxyurea—head and neck cancer	0.00191	0.00537	CcSEcCtD
Lacosamide—Dermatitis—Hydroxyurea—head and neck cancer	0.0019	0.00537	CcSEcCtD
Lacosamide—Headache—Hydroxyurea—head and neck cancer	0.00189	0.00534	CcSEcCtD
Lacosamide—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00188	0.0053	CcSEcCtD
Lacosamide—Muscle spasms—Docetaxel—head and neck cancer	0.00185	0.00522	CcSEcCtD
Lacosamide—CA2—lymph node—head and neck cancer	0.00184	0.00285	CbGeAlD
Lacosamide—Nausea—Hydroxyurea—head and neck cancer	0.00179	0.00506	CcSEcCtD
Lacosamide—Feeling abnormal—Fluorouracil—head and neck cancer	0.00179	0.00506	CcSEcCtD
Lacosamide—Anaemia—Docetaxel—head and neck cancer	0.00178	0.00501	CcSEcCtD
Lacosamide—Urticaria—Fluorouracil—head and neck cancer	0.00173	0.00487	CcSEcCtD
Lacosamide—Syncope—Docetaxel—head and neck cancer	0.00172	0.00487	CcSEcCtD
Lacosamide—Body temperature increased—Fluorouracil—head and neck cancer	0.00172	0.00485	CcSEcCtD
Lacosamide—Palpitations—Docetaxel—head and neck cancer	0.0017	0.00479	CcSEcCtD
Lacosamide—Loss of consciousness—Docetaxel—head and neck cancer	0.00169	0.00477	CcSEcCtD
Lacosamide—Chest pain—Docetaxel—head and neck cancer	0.00164	0.00462	CcSEcCtD
Lacosamide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00163	0.00459	CcSEcCtD
Lacosamide—Hypersensitivity—Fluorouracil—head and neck cancer	0.0016	0.00452	CcSEcCtD
Lacosamide—Dry mouth—Docetaxel—head and neck cancer	0.0016	0.00452	CcSEcCtD
Lacosamide—Confusional state—Docetaxel—head and neck cancer	0.00158	0.00446	CcSEcCtD
Lacosamide—Shock—Docetaxel—head and neck cancer	0.00154	0.00436	CcSEcCtD
Lacosamide—Nervous system disorder—Docetaxel—head and neck cancer	0.00154	0.00434	CcSEcCtD
Lacosamide—Pruritus—Fluorouracil—head and neck cancer	0.00154	0.00434	CcSEcCtD
Lacosamide—Skin disorder—Docetaxel—head and neck cancer	0.00152	0.0043	CcSEcCtD
Lacosamide—Diarrhoea—Fluorouracil—head and neck cancer	0.00149	0.0042	CcSEcCtD
Lacosamide—Dizziness—Fluorouracil—head and neck cancer	0.00144	0.00406	CcSEcCtD
Lacosamide—Insomnia—Docetaxel—head and neck cancer	0.00142	0.004	CcSEcCtD
Lacosamide—Paraesthesia—Docetaxel—head and neck cancer	0.00141	0.00398	CcSEcCtD
Lacosamide—Somnolence—Docetaxel—head and neck cancer	0.0014	0.00394	CcSEcCtD
Lacosamide—Vomiting—Fluorouracil—head and neck cancer	0.00138	0.0039	CcSEcCtD
Lacosamide—Dyspepsia—Docetaxel—head and neck cancer	0.00138	0.0039	CcSEcCtD
Lacosamide—Rash—Fluorouracil—head and neck cancer	0.00137	0.00387	CcSEcCtD
Lacosamide—Dermatitis—Fluorouracil—head and neck cancer	0.00137	0.00386	CcSEcCtD
Lacosamide—Headache—Fluorouracil—head and neck cancer	0.00136	0.00384	CcSEcCtD
Lacosamide—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00136	0.00382	CcSEcCtD
Lacosamide—Fatigue—Docetaxel—head and neck cancer	0.00135	0.00382	CcSEcCtD
Lacosamide—Constipation—Docetaxel—head and neck cancer	0.00134	0.00379	CcSEcCtD
Lacosamide—Feeling abnormal—Docetaxel—head and neck cancer	0.00129	0.00365	CcSEcCtD
Lacosamide—Nausea—Fluorouracil—head and neck cancer	0.00129	0.00364	CcSEcCtD
Lacosamide—Body temperature increased—Docetaxel—head and neck cancer	0.00124	0.0035	CcSEcCtD
Lacosamide—Hypersensitivity—Docetaxel—head and neck cancer	0.00116	0.00326	CcSEcCtD
Lacosamide—Asthenia—Docetaxel—head and neck cancer	0.00113	0.00318	CcSEcCtD
Lacosamide—Pruritus—Docetaxel—head and neck cancer	0.00111	0.00313	CcSEcCtD
Lacosamide—Diarrhoea—Docetaxel—head and neck cancer	0.00107	0.00303	CcSEcCtD
Lacosamide—Dizziness—Docetaxel—head and neck cancer	0.00104	0.00293	CcSEcCtD
Lacosamide—Vomiting—Docetaxel—head and neck cancer	0.000998	0.00282	CcSEcCtD
Lacosamide—Rash—Docetaxel—head and neck cancer	0.00099	0.00279	CcSEcCtD
Lacosamide—Dermatitis—Docetaxel—head and neck cancer	0.000989	0.00279	CcSEcCtD
Lacosamide—Headache—Docetaxel—head and neck cancer	0.000983	0.00277	CcSEcCtD
Lacosamide—Nausea—Docetaxel—head and neck cancer	0.000932	0.00263	CcSEcCtD
